A detailed history of Atlas Venture Life Science Advisors, LLC transactions in Generation Bio Co. stock. As of the latest transaction made, Atlas Venture Life Science Advisors, LLC holds 8,279,484 shares of GBIO stock, worth $18.3 Million. This represents 3.11% of its overall portfolio holdings.

Number of Shares
8,279,484
Previous 8,279,484 -0.0%
Holding current value
$18.3 Million
Previous $33.7 Million 30.71%
% of portfolio
3.11%
Previous 4.22%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$3.61 - $7.01 $2,194 - $4,262
608 Added 0.01%
8,279,484 $35.6 Million
Q4 2021

May 16, 2022

BUY
$5.99 - $24.97 $49.6 Million - $207 Million
8,278,876 New
8,278,876 $58.6 Million

Others Institutions Holding GBIO

About Generation Bio Co.


  • Ticker GBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,011,200
  • Market Cap $130M
  • Description
  • Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...
More about GBIO
Track This Portfolio

Track Atlas Venture Life Science Advisors, LLC Portfolio

Follow Atlas Venture Life Science Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Venture Life Science Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Venture Life Science Advisors, LLC with notifications on news.